KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Other Gross PP&E Adjustments (2016 - 2026)

Bio-Rad Laboratories has reported Other Gross PP&E Adjustments over the past 18 years, most recently at -$161.9 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments fell 5.68% to -$161.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$161.9 million through Mar 2026, down 5.68% year-over-year, with the annual reading at $1.6 billion for FY2025, 10.43% up from the prior year.
  • Other Gross PP&E Adjustments was -$161.9 million for Q1 2026 at Bio-Rad Laboratories, down from $1.6 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $1.6 billion in Q4 2025 and troughed at -$190.4 million in Q2 2025.
  • The 5-year median for Other Gross PP&E Adjustments is $1.3 billion (2022), against an average of $656.2 million.
  • Year-over-year, Other Gross PP&E Adjustments skyrocketed 1014.69% in 2023 and then plummeted 113.79% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$153.2 million in 2022, then skyrocketed by 1014.69% to $1.4 billion in 2023, then rose by 5.41% to $1.5 billion in 2024, then increased by 10.43% to $1.6 billion in 2025, then crashed by 109.93% to -$161.9 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Other Gross PP&E Adjustments are -$161.9 million (Q1 2026), $1.6 billion (Q4 2025), and -$180.3 million (Q3 2025).